CVS Flashcards

1
Q

Active cardiac conditions (4) that warrant delay of elective surgery for further evaluation or treatment

A

(1) Unstable coronary syndromes, (2) decompensated HF, (3) significant arrhythmia, (4) severe valvular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Patients with an episode of pulmonary edema should delay elective surgery for this duration

A

1 week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For patients who received angioplasty and stenting, elective surgery should be postponed for at least this duration after bare-metal stent placement

A

4-6 weeks

12 months if drug-eluting stent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chest pain is the presenting symptom of postoperative MI in only this percentage of patients

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Peak incidence of postoperative MI is during this number of hours after surgery

A

24 to 48 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Classic symptom of peripheral arterial disease

A

Intermittent claudication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ankle-brachial index in peripheral arterial disease

A

0.90 or less

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When the ABI is greater than 1.40, this test will provide a better assessment of lower extremity perfusion

A

Toe-brachial index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraindications to cilostazol (2)

A

Low LVEF or history of HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Size of asymptomatic AAA that warrants surgical repair

A

5.5 cm or greater

or those growing 0.5 cm or more per year, or symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Monitoring for unrepaired AAA measuring 4.0 to 5.4 cm

A

Ultrasound every 6 months

Every 2-3 years for smaller AAAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Patients should be counselled against pregnancy if the aortic root diameter exceeds this value

A

4 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Class of drugs that reduce the rate of thoracic aortic dilation in thoracic aneurysms

A

Beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Confirmatory test for coarctation of the aorta

A

Magnetic resonance angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chest x-ray findings in coarctation of the aorta (2)

A

“Figure 3” sign and notching on the undersides of the posterior ribs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Balloon dilation is indicated in coarctation of the aorta if the pressure gradient exceeds this value

A

20 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A golden or brightly refractile cholesterol body within a retinal artery; pathognomonic for atheroembolism

A

Hollenhorst plaque

18
Q

Most common cause of ventricular rates 30 to 50 per min

A

Third-degree block

18
Q

Pulmonary side effects of adenosine (2)

A

Cough and bronchospasm

19
Q

Duration of anticoagulation prior to elective cardioversion for patients with chronic AF

A

3 weeks

19
Q

Diagnostic procedure of choice for prosthetic valve dysfunction

A

TEE

20
Q

Addition of this drug to warfarin further decreases the risk of thromboembolism and is recommended in all patients with prosthetic heart valves

A

Aspirin

21
Q

Most common cause of significant MR

A

Mitral valve prolapse

22
Q

Prolonged use of these drugs (3) is associated with chronic MR

A

Ergotamine, pergolide, or cabergoline

* Goldman - also dexfenfluramine and fenfluramine

23
Q

Target MAP for patients with acute MR

A

Less than 60 mmHg

24
Q

Aortic stenosis and gastrointestinal bleeding due to acquired von Willebrand disease

A

Heyde syndrome

25
Q

Treatment for acute pericarditis that increases risk of recurrence

A

Corticosteroids

26
Q

Most common ECG abnormality associated with cardiac amyloidosis

A

Low voltage complexes

27
Q

Third-line agent for HCM (after beta blockere and CCBs)

A

Disopyramide

28
Q

Three major risk factors for sudden death in HCM

A

Prev cardiac arrest, spontaneous sustained VT, first-degree relative with sudden death

29
Q

Serum BNP level that effectively excludes HF as a cause of acute dyspnea

A

Less than 100 pg/mL

30
Q

ICD is indicated for patients with HF and this EF

A

35% or less

31
Q

Biventricular pacing is indicated for NYHA class III-IV HF with this EF and QRS duration

A

35% or less; more than 120 ms

32
Q

Biventricular pacing is indicated for NYHA class II HF with this EF and QRS duration

A

30% or less; more than 150 ms

33
Q

Indication for cardiac transplantation in HF

A

VO2max less than 14 mL/kg/min or less than 50% age-predicted maximum

34
Q

Appropriate stress test for patients with nonspecific baseline ECG changes or complete RBBB

A

Exercise ECG

35
Q

Appropriate stress test for patients with LBBB

A

Vasodilator MPI

36
Q

Appropriate stress test for patients with ventricular paced rhythm

A

Pharmacologic stress MPI

37
Q

Dose of ranolazine should be reduced when taken together with these anti-ischemic drugs (2)

A

Diltiazem or verapamil

38
Q

Preferred aldosterone antagonist in acute MI

A

Eplerenone

39
Q

ICD implantation after STEMI should be done after this number of days since MI

A

40 days

40
Q

All post-MI patients should be screened for this psychiatric condition as it is associated with increased hospitalization and death

A

Depression